1 / 10

Zika virus vaccines are gaining popularity, and FDA has passed priority review voucher system for it.

Zika virus is affecting people staying in Zika-infested regions and also the infection is linked with many babies being born with underdeveloped brains. Key opportunities include the need for vaccines for immunization & prevention of further spread of Zika virus infection and for treatment of Zika-linked birth defects.

ketaki
Download Presentation

Zika virus vaccines are gaining popularity, and FDA has passed priority review voucher system for it.

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Zika Virus Vaccines Market Opportunities and Forecasts, 2014 – 2022 PUBLISHED DATE: 11-JAN-17

  2. Zikavirus belongs to Flavivirus, a genus of the viruses in the Flaviridae family, and it is transmitted via Aedes mosquito, blood transfusion, sex, and from an infected pregnant woman to her fetus.  • The infection of this virus can cause adverse effects such as neurological problems and congenital birth defects in the fetus. • Zikavirus is affecting people staying in Zika-infested regions and also the infection is linked with many babies being born with underdeveloped brains. • The outbreak of Zika virus infection in Latin American Countries, especially in Brazil, in last two years; its continuous spread in North America, Asia-Pacific, and Middle East & Africa • Multiple players are in process of vaccine development based on various techniques such as recombinant, live attenuated, whole inactivated, nucleic acids, and viral vectors. • LAMEA showed the highest growth rate, accounting for major share in 2015, and is projected to continue this trend. Currently, nearly more than 22 countries of Latin America have reported active Zika virus infection. ZIKA VIRUS VACCINES MARKET- INTRODUCTION

  3. ZIKA VIRUS VACCINES MARKET-KEY FINDINGS • LAMEA accounted for approximately half of the share of the global market in 2015, and is projected to grow at a CAGR of 5.0%. • Asia-Pacific is the second largest potential market, and is expected to grow at a CAGR of 5.6% • Brazil has the highest potential and projected to grow at a CAGR of 7.2% during the forecast period in rapid adoption scenario.

  4. TABLE OF CONTENTS • INTRODUCTION • EXECUTIVE SUMMARY •  MARKET OVERVIEW • FORECAST SCENARIO ANALYSIS OF ZIKA VIRUS VACCINES • POTENTIAL ANALYSIS OF ZIKA VIRUS VACCINE MARKET, BY GEOGRAPHY • COMPANY PROFILES

  5. GLOBAL POTENTIAL ANALYSIS OF ZIKA VIRUS VACCINES MARKET SEGMENTATION

  6. TOP INVESTMENT POCKETS

  7. THAILAND: POTENTIAL MARKET FOR ZIKA VIRUS VACCINES ($MILLION), (2017-2022)

  8. ZIKA VIRUS VACCINES MARKET- BY GEOGRAPHY  North America, Europe, Asia Pacific, LAMEA

  9. COMPANYPROFILES Takeda Pharmaceutical Co. Ltd Bharat Biotech International Ltd NewLink Genetics Co Inovio Pharmaceuticals GeneOne Life Science GlaxoSmithKline plc Sanofi S.A.

  10. THANK YOU Thank You! For More Details Visit us at https://www.alliedmarketresearch.com/zika-virus-vaccines-market Follow Us On

More Related